Trial intelligence / Profile preview

Neoral versus tacrolimus after liver transplantation for hepatitis C cirrhosis

2005-001221-28Phase 4Completed

Sponsor
Novartis
Start
Sep 2005
Modality
RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, randomised, open-label trial in hepatitis C virus infection and hepatic fibrosis comparing Neoral arm with Tacrolimus arm (2 arms). Started Sep 2005; status: completed.

02

Drugs

cyclosporinetacrolimus
03

Conditions

hepatitis C virus infectionhepatic fibrosis

Beyond the preview

Go deeper on 2005-001221-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001221-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call